TABLE 1.
Characteristics and outcomes of the 139 study subjects
| Positive for SARS‐CoV‐2 (n = 29) | Negative for SARS‐CoV‐2 (n = 110) | p values | |
|---|---|---|---|
| Sex | |||
| F | 16 (55%) | 53 (48%) | 0.64 |
| M | 13 (45%) | 57 (52%) | |
| On admission | |||
| Triage code | |||
| 1 | 0 | 3 (2%) | 0.36 |
| 2 | 20 (69%) | 59 (54%) | |
| 3 | 9 (31%) | 46 (42%) | |
| 4 | 0 | 3 (2%) | |
| Appeared ill | 0 | 11 (10%) | 0.16 |
| Symptoms | |||
| Fever | 19 (66%) | 30 (27%) | 0.0001 |
| Cough and rhinitis | 9 (31%) | 30 (27%) | 0.16 |
| Respiratory distress | 4 (14%) | 18 (16%) | 0.21 |
| Vomiting | 1 (3%) | 10 (9%) | 0.22 |
| Irritability | 0 (0%) | 6 (5%) | NA |
| Others | 6 (21%) | 12 (11%) | 0.09 |
| Clinical outcomes | |||
| Median length of hospitalisation (days) | 1 | 1 | |
| Respiratory support a | 0 | 10 (9%) | 0.12 |
| Antibiotic therapy | 5 (17%) | 17 (15%) | 0.78 |
| Ward admitted to | |||
| PICU/NICU | 0 | 31 (28%) | 0.0003 |
| PED (OBI) | 27 (93%) | 71 (65%) | 0.0024 |
| General ward | 2 (7%) | 8 (7%) | 1 |
| Final diagnosis, n (%) | |||
| COVID‐19 | 29 (21%) | ||
| Bronchiolitis | 30 (22%) | ||
| Upper respiratory tract infection | 18 (13%) | ||
| Urinary tract infection | 11 (8%) | ||
| Fever of unknown origin | 8 (6%) | ||
| Gastroenteritis | 4 (3%) | ||
| Acute otitis media | 3 (2%) | ||
| Other | 36 (26%) | ||
Abbreviations: NICU, neonatal intensive care unit; OBI, brief intensive observation; PICU, paediatric intensive care unit; PED, paediatric emergency department.
a
Respiratory support: oxygen, high‐flow nasal cannula, continuous positive airway pressure.